INTRODUCTION
The term craniometaphyseal dysplasia (CMD) was coined by Jackson et al. (1) in 1954 for a rare disorder involving progressive thickening of skulls and widening of metaphyses of tubular bones throughout the life. Other reported abnormalities of CMD include maxillary retrusion, mandibular prognathism and hyperostosis of jawbones (2) (3) (4) . CMD can be diagnosed early in infancy due to difficulties with feeding and breathing caused by obstruction of the nasal lumen (5 -7) . Hyperostosis of the skull leads to narrowing of cranial foramina and obstruction of cranial nerves II, III, VI, VII and VIII by bony encroachment (8 -10) . Symptomatic Chiari I malformation, characterized by displacement of the cerebellar tonsils beneath the foramen magnum into the cervical spinal cord, has been reported (11, 12) . Treatment of CMD is limited to surgical intervention for decompression of obstructed foramina, to slow progression of facial paralysis, to reduce visual and auditory disturbances and to improve facial appearance.
The little we know about the pathophysiology of CMD is mainly based on a few case reports. Histopathological studies of CMD patients showed inconsistent findings, which include increased numbers of osteoblasts (1, 13) , no osteoclasts in the endosteal or periosteal layers (14) , hyperostotic bone with defective mineralization of bone matrix (15) , elevated numbers of osteoclasts and osteoclastic surface area (16) and increased bone formation and bone resorption (17) . Yamamoto et al. (18) reported lack of expression of a vacuolar proton pump in osteoclasts of a single CMD patient. From these reports, it is unclear how osteoblastogenesis and osteoclastogenesis in CMD patients are affected.
CMD occurs sporadically or is transmitted as an autosomal dominant (AD) or autosomal recessive (AR) trait. Mutations located in cytoplasmic domains close to the C-terminus of the human ANK gene (ANKH) were identified for the AD form of CMD (19, 20) . Database searches with the full-length mouse Ank gene have shown a high degree of sequence conservation among vertebrates, including zebrafish, rats, mice and human, indicating that ANK may play a crucial role in physiological processes (20, 21) . Although the topology of the ANK protein has not been experimentally confirmed and the precise structure of ANK is still unknown, ANK is proposed to act as a pyrophosphate (PPi) transporter to channel intracellular PPi into extracellular matrix (21) . Extracellular PPi (ePPi) in a physiological concentration acts as a potent inhibitor of mineralization. Low concentrations of ePPi lead to excess hydroxyapatite (HA) deposition, while supersaturation of ePPi promotes calcium pyrophosphate dihydrate (CPPD) crystal formation. On the other hand, Pi is a major component and a promoter of HA formation. A tightly controlled balance between ePi and ePPi is required to maintain normal bone mineral content.
Homeostasis of Pi/PPi is primarily maintained by the concerted activities of ANK and other regulators: PC-1 (plasma cell membrane glycoprotein 1, protein encoded by Enpp1), which generates PPi from extracellular and intracellular nucleoside triphosphate (ATP) and TNAP (protein encoded by Tnap), which hydrolyzes ePPi to generate Pi. Deficiency of any of these three proteins can lead to mineral-related pathological conditions in bone. Tiptoe walking (ttw/ttw) mice carry a naturally occurring nonsense mutation in PC-1 and develop accelerated bone formation as well as ectopic ossification in spinal and periarticular ligaments (22) . Tnap knock-out mice (Akp2 2/2 ), on the other hand, replicate features of human infantile hypophosphatasia, including rachitic changes, osteopenia and spontaneous fracture (23) . Ank ank/ ank and Ank null/null mice, which are lacking functional ANK protein, show progressive arthritic destruction of joints with increased HA deposition eventually leading to complete rigidity and death around 6 months of age (24 -26) . Interestingly, Ank null/null mice exhibit some characteristic features seen in CMD patients such as increased thickness of skull bones, fusion of middle-ear bones, narrowing of foramen magnum and decreased trabeculation of metaphyses in femurs (27) . However, Ank null/null mice do not replicate obliteration of nasal sinuses, mandibular prognathism with massive jawbones, hypertelorism and flaring metaphyses in long bones. Differences in phenotype between human CMD and Ank null/null mice suggest that the mechanism of ANKH mutations leading to CMD in humans is not merely a loss of function of PPi transport.
We have generated a knock-in (KI) mouse model for CMD expressing a human ANK mutation (Phe377 deletion), which develop many of the features that are characteristic for CMD patients (28) . These mice exhibit increased bone mass in craniofacial bones, especially the mandibles and excessive trabecular bone in diaphyses of long bones, while metaphyses are undertrabeculated. Surprisingly, the cortex of Ank KI/KI long bones is hypomineralized. Although histomorphometry indicated increased osteoclast number in Ank KI/KI mice, the in vitro cultures showed decreased osteoclastogenesis (28) . Here, we investigate the effects of the Phe377del mutation of ANK on osteoblastogenesis and osteoclastogenesis at a cellular level in the Ank KI mouse model.
RESULTS

Effects of Phe377del Ank mutation on osteoblastogenesis
To study the mutational effects on bone, we first compared wild-type and mutant Ank RNA levels in calvarial and femoral bones and examined whether Ank expression was modulated in vitro during calvarial osteoblast differentiation by quantitative PCR (Fig. 1A and B Table S1 ).
Ank KI/KI bone marrow stromal cell cultures (BMSCs) also contained significantly fewer ALP-positive cell clusters than Ank +/+ cultures, which was likely due to a decreased number of adherent cell colonies as shown by crystal violet staining ( Fig. 1D and E) . We next visualized the mineral nodule deposition by alizarin red S staining and quantified calcium binding to alizarin red by colorimetric detection as an indicator for calcification (Fig. 1F) Regulation of ePPi level in Ank KI/KI osteoblasts ANK has been proposed to act as a PPi transporter to channel intracellular PPi to the extracellular matrix (21) . ePPi is an inhibitor for HA deposition during physiological bone mineralization. Since we observed a hypomineralized phenotype in Ank KI/KI mice and in osteoblast cultures, abnormal ePPi levels were a possible reason for abnormal HA crystal deposition. We compared the ePPi levels of cultured Ank +/+ and Ank KI/ KI calvarial osteoblasts and surprisingly, we found no significant difference between the two groups ( Fig. 2A, left panel) . In Ank null/null cells, which lack ANK protein, the ePPi level was, as expected, significantly lower than in wild-type cultures ( Fig. 2A, right Table S2 ). We also examined the expression of these marker genes in RNA isolated from 8-to 10-week-old calvarial and femoral bones and found no significant differences between Ank Table S2 ). A possible explanation may be that the differentiation stages of osteoblasts are heterogeneous in bone, while the populations are somewhat more homogeneous in culture systems at days 0, 7, 14 and 21. Interestingly, Phex (phosphate regulating gene with homologies to endopeptidases on the X chromosome) was also significantly decreased in Ank KI/KI osteoblast cultures (Fig. 3A ). An inactivating mutation of Phex is known to cause X-linked hypophosphatemia (XLH) in humans and impaired mineralization of bone and dentin in Hyp mice (29 -32 (Fig. 3B ) but decreased in femurs (Fig. 3C) . It is unclear whether the differential expression of Mepe between calvarial and femoral bones reflect the differences between intramembranous and endochondral bone formation in Ank KI/KI mice. FGF23 can regulate bone mineralization via a systemic effect through interaction with KLOTHO in the kidney (33, 34) or via local effects in the bone environment where Fgf23 is expressed (35) . Overexpression of FGF23 suppresses not only osteoblast differentiation but also matrix mineralization in fetal rat calvarial cell cultures (36) . Furthermore, overexpression of Fgf23 in transgenic mice results in hypomineralization of bone and in hypophosphatemia (33) . Because of the remarkably increased Fgf23 levels, we next examined whether serum levels of calcium and phosphate are affected in Ank KI/KI mice.
Lower calcium and phosphorus serum levels in Ank such as externally produced hormones, cytokines or other factors. Since we found defects intrinsic to Ank KI/KI osteoblasts and osteoclasts as well as abnormal serum phosphorus and calcium, we wanted to determine whether local factors in bone or systemic factors are major contributors to the CMD-like skeletal phenotype in Ank KI/KI mice using reciprocal bone explantation (37, 38) .
Radiographic images of 4.5-day-old femurs of Ank +/+ and Ank KI/KI donor mice showed that they were very similar in shape and trabeculation (Fig. 4) . One Ank +/+ and one Ank KI/KI femur were transplanted into the lateral back muscles (one femur each side) of 4-week-old Ank +/+ and Ank KI/KI recipient mice. Transplanted bones were harvested and analyzed when the mice were 7 weeks old because we had previously observed lower serum calcium and phosphorus levels in Ank KI/KI mice at the age of 6 weeks. Wild-type bones transplanted into wild-type mice and Ank KI/KI bones into Ank KI/KI mice maintained their phenotypic characteristics and grew in size, which suggests that surgical procedures were not a factor interfering with data interpretation. Since we had previously found extensive trabeculation in diaphyses of Ank KI/KI mice (28), we measured the bone volume of diaphyses by mCT. We chose measuring diaphyseal bone volume rather than metaphyseal bone volume because growth plates are easily damaged during resection from back muscles and may skew measurements. Our results showed that Ank KI/KI femurs transplanted into Ank KI/KI mice developed significantly more bone volume than Ank +/+ bones explanted into either Ank +/+ or Ank KI/KI mice (Fig. 4) . We also found increased diaphyseal bone in Ank KI/KI bones transplanted into Ank +/+ mice compared with Ank +/+ bones that were transplanted into Ank +/+ or Ank KI/KI recipient mice; however, the difference was not statistically significant (Fig. 4) . Because Ank KI/KI bones that were transplanted into Ank +/+ mice had less trabecular bone deposition in diaphyses than transplanted into Ank KI/KI mice, it appears that the influence of hormonal (systemic) factors cannot be ruled out. However, based on the observation that Ank KI/KI bones developed the abnormal bone shape as well as excessive diaphyseal trabeculation when transplanted into both, wild-type and mutant recipient animals, we suggest that local factors play a more important role in the development of a CMD-like skeletal phenotype.
Decreased osteoclastogenesis in peripheral blood cultures of CMD patients
We have shown that mouse Ank KI/KI bone marrow-derived macrophage (BMM) cultures form significantly fewer and smaller osteoclasts during in vitro osteoclast differentiation and have significantly reduced mineral resorption on calcium-phosphate-coated slides as well as on bone chips (28) . To examine whether similar findings can be observed in CMD patients, we compared osteoclasts derived from peripheral blood mononuclear cells of adult CMD patients to age-and sex-matched healthy controls. Cultures from CMD patients formed less TRAP + multinucleated cells and resorbed less mineral on osteologic slides ( Fig. 5A and B) . Although the number of samples (patients n ¼ 2; controls n ¼ 7) is small due to the rarity of the disorder, the outcome is perfectly in line with previous findings in Ank KI/KI mice suggesting that osteoclastogenesis in CMD patients is impaired by mutant ANK. (39) . In all the culture systems, we detected remarkably increased Ank levels in mature osteoclasts compared with osteoclast progenitors (Fig. 6A, Supplementary Material, Fig. S1 ). We conclude that Ank may play an important role during osteoclastogenesis, which is confirmed by the in vitro observation that the Phe377del ANK mutation leads to impaired osteoclastogenesis in Ank KI/KI mice and in CMD patients. Fig. S2 ). However, mature osteoclasts derived from isolated progenitors of Ank KI/KI BMM cultures presented with reduced cell size, disrupted actin rings (Fig. 6B) and decreased cell migration. The actin ring plays a critical role in bone resorption by forming a seal between the osteoclast and the bone surface (40) . Using a live-cell time-lapse imaging system and by quantifying the migratory velocity with MetaMorph software, we observed that movement was greatly reduced in Ank KI/KI BMMs (Ank +/+ : Ank KI/KI ¼ 2.25 + 0.447:1 + 0.248; n ¼ 15; P , 0.05). In addition, fusion efficiency in Ank KI/KI BMM cultures (nuclei number of mature osteoclasts divided by total number of nuclei) was decreased (Fig. 6C) . The latter observation suggests that less mononuclear cells participate in fusion and maturation of Ank KI/KI osteoclasts in culture. We examined expression levels of osteoclast markers in RNA samples isolated from day 0, 2 and 5 BMM cultures with M-CSF and RANKL stimulation (30 ng/ml). Day 0 mRNA was prepared from untreated freshly isolated BMMs, which contains osteoclast precursors. Samples from day 2 and 5 cultures represent pre-fusion osteoclasts and mature osteoclasts. We did not detect differential expression of Ank, Oscar, TRAP, cathepsin K, Nfatc1, Mmp9, ATP6v0d2 and AQP9 (data not shown). However, DC-Stamp, critical for fusion, was significantly decreased on day 2 of Ank KI/KI BMM cultures (Fig. 6D) . Stimulation by osteoblasts plays a crucial role during osteoclast formation (41, 42) . To study whether decreased osteoclastogenesis in Ank KI/KI mice depends at least in part on intrinsic defects or on non-cell-autonomous effects, meaning lack of support from Ank KI/KI osteoblasts for osteoclastogenesis, we performed mCOB -BMM cocultures. We analyzed mineral resorption on osteologic slides and found that cocultures of Ank +/+ mCOBs with Ank +/+ BMMs had the most mineralized area resorbed, while cocultures of Ank KI/KI mCOBs with Ank KI/KI BMMs had the least (Fig. 6E) , as was expected. Replacement of Ank KI/KI with Ank +/+ mCOBs or BMMs partially restored the percentage of resorbed area. The fact that resorption capability of Ank KI/KI osteoclasts is only partially rescued suggests that reduced osteoclastogenesis of Ank KI/KI cultures is caused by a combination of cell-autonomous effects and reduced osteoblast-mediated osteoclastogenesis.
Mcsf and Rankl, which stimulate osteoclastogenesis, and Opg, which suppresses osteoclast differentiation, are the bestdescribed signals transferred from osteoblasts to osteoclasts (43, 44 Table S3 ). However, rescue of bone shape could not be expected as bone shape is already fully developed in 4-week-old mice. Tissue density remained unchanged, which indicates that bone mineral quality is not controlled by the osteoclast phenotype. Furthermore, Ank +/+ mice receiving Ank KI/KI bone marrow showed a tendency of increased bone mass in calvarial, mandibular and femoral bones, although some parameters did not reach significant differences compared with Ank +/+ mice that had received Ank +/+ bone marrow. This may be due to high biological variability between animals or an insufficient recovery period. In conclusion, this data suggests that abnormal osteoclasts partially contribute to the increased bone mass phenotype in Ank KI/KI mice.
DISCUSSION
This study was intended to better describe the pathogenic mechanism leading to a CMD-like phenotype in the Phe377del Ank KI mouse model, which replicates features of CMD patients on a morphological, cellular and serological level. Because of its rarity, CMD has been understudied and while we could confirm some of the mouse data by in vitro studies with cells from CMD patients, other data will need to be confirmed in follow-up experiments with tissues or cells from CMD patients as they become available.
To study the effect of CMD mutant ANK on osteoblast differentiation and mineralization, we used mCOB and mouse BMSCs representing osteoblasts from craniofacial bones and from long bones. We had previously shown a significantly higher serum level of total ALP in Ank KI/KI mice (28); however, the ALP staining was comparable between Ank +/+ and Ank KI/KI calvarial osteoblast cultures. ALP is found primarily in liver and bone but is also produced by intestine, kidney and placenta. Paradoxically, we observed decreased ALP staining in Ank KI/KI BMSC cultures. Although increased serum ALP is often used as a biochemical marker for high bone turnover, it is not a bone-specific marker due to high cross-reactivity with liver ALP. ALP staining from osteoblast cultures appears to be more indicative for bone mineralization than serum ALP in these mice. However, the cellular heterogeneity in cultures should also be considered. We believe that decreased ALP-stained colonies in Ank KI/KI BMSC cultures correlate with decreased numbers of attached colonies as shown by crystal violet staining, which raises the possibility of a shift in mesenchymal cell populations of bone marrow in Ank KI/KI mice.
We determined the mineralization potential of mouse osteoblasts with von Kossa staining, which shows the binding of phosphate to silver and alizarin red, which specifically chelates with calcium. Both assays showed less mineralized nodules in Ank KI/KI mCOB and BMSC cultures than in Ank +/+ cultures suggesting that the Ank Phe377deletion mutation suppresses osteoblast mineralization. These in vitro data reflect the hypomineralized skeletal phenotype of Ank KI/KI mice. Since bone samples from CMD patients rarely become available, detailed examination of bone quality and mineralization has never been reported. Literature references to sclerotic cranial bone are based on high radiopacity of radiographic images, which may be based on craniofacial hyperostosis rather than on hypermineralization of normal thickness bone. In fact, Elcioglu and Hall (15) report hypomineralization in one of their patients.
We hypothesized that the Phe377del mutation in ANK causes abnormal mineralization (i) by disrupting the physiological concentration of ePPi or (ii) by altering expression of genes that regulate mineralization in osteoblasts. A recent biochemical study used a sensitive radioflux method to test the transport activity of mutant ANK proteins in frog oocytes and showed greatly reduced PPi transport in ANK carrying CMD mutations (C331R and C389R) (27) . Surprisingly, we detected no difference in the ePPi levels between Ank +/+ and Ank KI/KI calvarial osteoblasts but found that the enzymatic activity of PC-1 in Ank KI/KI calvarial osteoblasts was significantly increased. Higher PC-1 activity is expected to generate more ePPi. At normal concentrations, ePPi acts as a regulator of HA crystal formation and at high concentrations promotes CPPD formation as seen in chondrocalcinosis patients. Previously, we showed by wide-angle X-ray diffraction that no CPPD crystals are present in Ank KI/KI tibiae or scapulae, indirectly suggesting that ePPi levels in Ank KI/KI bone were not excessively high (28) . Based on these data, we propose that mutant ANK is likely to transport less PPi into the extracellular matrix and that the ePPi level in Ank KI/KI osteoblasts is maintained by increased PC-1 activity.
In the late stage of osteoblast differentiation but not in early stages of osteoblastogenesis of Ank KI/KI mCOB cultures, the expression of genes including Mmp13, Ocn, Runx2 and Osx was reduced. In addition, we found decreased Phex expression in Ank KI/KI calvarial osteoblasts. Inactivating mutations of Phex result in hypophosphatemia and hypomineralization in XLH patients and in Hyp mice (29 -32) . These data are in line with our earlier findings that mineralization is decreased in Ank KI/KI osteoblast cultures and in bone of Ank KI/KI mice and suggest that the Phe377del Ank mutation affects gene expression during osteoblastogenesis.
A recent study showed that the conditional deletion of Phex in osteoblasts alone is sufficient to reproduce hypophosphatemia and to increase serum FGF23 in Hyp mice (45) . Since Phex was decreased in Ank KI/KI calvarial osteoblast cultures, we examined the expression of Fgf23 and found that the level in calvarial osteoblast cultures was very low without significant differences between Ank +/+ and Ank KI/KI cultures. In Hyp mice, PHEX is absent in osteoblasts but FGF23 levels increase only when osteoblasts differentiate into osteocytes (34, 38) . Therefore, we decided to examine Fgf23 levels directly in calvarial and femoral bones, which contain (35) . In a preliminary study, we did not find kidney malfunctions or gross-histological differences in kidney morphology in 10-week-old Ank KI/KI male mice. To our knowledge, FGF23 serum levels have not been studied in CMD patients. More detailed studies examining the roles of increased Fgf23 on bone homeostasis in Ank KI/KI mice through local or systemic effects are needed.
Osteoclasts are multinucleated resorptive cells derived from the monocyte-macrophage lineage (47) . In Ank KI/KI BMM cultures, we detected significantly reduced numbers of multinucleated osteoclasts and a stark reduction in mineral resorption. When we compared osteoclast cultures derived from peripheral blood of CMD patients to age-and gendermatched healthy control subjects, we also found decreased numbers of multinucleated osteoclasts and reduced mineral resorption in cultures derived from CMD patients. At a first glance, these in vitro experiments seem to be conflicting to our in vivo data, which showed increased serum TRAP levels and increased osteoclast numbers in Ank KI/KI mice (28) . However, we believe that the increased osteoclast numbers compensate for dysfunctional osteoclasts, which are unable to resorb bone at a normal rate. The reduced resorption capability of osteoclasts in Ank KI/KI mice and CMD patients may explain the hyperostotic phenotype of craniofacial bones and extensive trabeculation in diaphyses.
Several processes are required for mature osteoclasts to resorb bone, including attachment of osteoclasts to bone matrix, formation of the sealing zone and ruffled border, polarization of the plasma membrane, synthesizing and trafficking acids and enzymes onto resorbed bone surface. Our studies showed that reduced osteoclastogenesis in Ank KI/KI BMM cultures may depend on at least three features: (i) reduced fusion and migration capability; (ii) disrupted actin ring formation; and (iii) abnormal osteoblast -osteoclast communication.
The dendritic cell-specific seven-transmembrane protein (DC-STAMP) is an essential factor for cell -cell fusion in osteoclasts. Studies using DC-STAMP-deficient mice have shown that multinucleation is a prerequisite for osteoclast activity (48, 49) . These DC-STAMP-deficient mice only produce mononuclear osteoclasts and suffer from osteopetrosis due to reduced bone resorption. We plated equal numbers of Ank +/+ and Ank KI/KI BMMs in parallel cultures and found that fewer nuclei fused to form mature osteoclasts in Ank KI/KI cultures, meaning the ratio of mononuclear cells to multinucleated cells (more than three nuclei) was higher in Ank KI/KI cultures. We consistently detected delayed expression of DC-Stamp in Ank KI/KI pre-fusion osteoclasts. Moreover, our live-cell imaging data provided evidence of decreased mobility of Ank KI/KI cells, which may contribute to reduced frequency of fusion. Subsequently, we doubled or quadrupled the cell density and observed increased formation of multinucleated osteoclasts (data not shown). Multinucleated syncytia that developed in Ank KI/KI BMM cultures, however, did not spread out and migrate which may negatively affect their resorption activity. Taken together, our in vitro experiments suggest a complex osteoclast phenotype in Ank KI/KI BMMs and provide convincing evidence for linking mutant ANK to migration defects.
Osteoclasts attach to bone matrix during resorption and undergo cellular reorganization resulting in the formation of an actin ring structure known as sealing zone, which surrounds the ruffled border. The sealing zone interacts tightly with the bone surface via integrin heterodimeric receptors and provides an acidic environment between resorption lacunae and extracellular fluid secreted from osteoclasts. Disruption of the sealing zone leads to defective bone resorption and to an osteopetrotic phenotype in Pyk2 2/2 mice (50). Destaing et al. (51) demonstrated that podosome organization and actin polymerization are a highly dynamic process by using live confocal imaging and fluorescence recovery after photobleaching analysis in single osteoclasts expressing actin GFP. In addition, regulation of sealing zone formation is a complex process and involves podosome-associated proteins, adapter proteins, kinases, Rho GTPase and enzymes (52, 53) . We observed disrupted actin staining of Ank KI/KI BMMs but whether the ANK mutation affects actin turnover directly or cell signals associated with actin remodeling remains to be determined. Nonetheless, these data support our hypothesis that the ANK Phe377del mutation causes a cell-autonomous defect in Ank KI/KI osteoclasts. BMT studies have shown some successful engraftment of normal bone marrow in osteopetrosis patients resulting in amelioration of symptoms after transplantation (54, 55) . We expected that replacing abnormal osteoclasts with wild-type cells in Ank KI/KI mice can partially correct the skeletal phenotype. Since the pathogenesis of Ank KI/KI mice involves not just bone resorption by osteoclasts, full rescue is unlikely to be achieved by BMT, especially if the recipient mice are older. Eight weeks after transplantation into 4-week-old recipient mice, we started to detect decreased bone mass in hyperostotic mandibles and correction of extensive trabeculation in diaphyses in Ank KI/KI mice that had received Ank +/+ bone marrow. The age when mice receive the transplant is important to achieve the optimal rescue effects. Adult mice and rats with congenital osteosclerosis (oc/oc mice) have not shown significant improvements after BMT (56, 57) , whereas neonatal mice, even with only 20% replacement efficiency, showed some degree of rescue (58) . A case report showed that a successful hematopoietic engraftment performed in a child at the age of 8 years failed to correct osteopetrosis, which may be due to the late attempt of transplantation (59) . Most osteopetrosis patients are transplanted under the age of 2 years (54, 55) .
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In summary, we have identified defects in both osteoblasts and osteoclasts in Ank KI/KI mice, a mouse model for CMD. To date, treatment for CMD patients is very limited and surgery appears to be the only option for patients with life-threatening symptoms. Our studies have uncovered that in addition to impaired function in mesenchymal cells, the CMD-causing ANK mutation also affects osteoclasts, which can be a target for treatment. Further studies are needed to determine whether BMT performed at young age may be able to delay cranial hyperostosis and therefore neurological symptoms for CMD patients with a severe skeletal phenotype.
MATERIALS AND METHODS
Mice
Ank
KI/KI mice carrying a human CMD mutation [a deletion of TTC 1130 -1132 (phenylalanine 377) in exon 9 of Ank] were generated in the Gene Targeting and Transgenic Facility (GTTF) at the University of Connecticut Health Center (UCHC). Mice were bred from a 129/Sv into a C57Bl/J6 background (N5). Detailed in vivo skeletal characterization of this CMD mouse model was previously published (28) . Ank null/null mice (26) were maintained in a mixed background of FVB and C57Bl/J6 (kindly provided by Dr David Kingsley, Stanford University). All work involving animals was approved by the Animal Care Committee (ACC) of UCHC.
Mouse calvarial osteoblast cultures (mCOBs)
Calvariae from postnatal day 4 -7 mice were isolated and digested with 0.05% trypsin (Invitrogen -Gibco) and 0.15% collagenase (Type II; Sigma Aldrich) for four cycles (20 min/cycle) at 378C. Only cells from digests 2 -4 were collected. Cells were plated at a density of 10 000 per cm 2 in DMEM (Invitrogen -Gibco) and cultured until confluent. Cells were then maintained in osteoblast differentiating medium (a-MEM; Invitrogen -Gibco) containing 10% fetal bovine serum (FBS; Hyclone), 100 IU/ml penicillin, 100 mg/ml streptomycin (Invitrogen-Gibco), 50 mg/ml ascorbic acid and 4 mM b-glycerophosphate (Sigma). The medium was changed every 2-3 days.
Mouse bone marrow stromal cell cultures (mBMSCs) mBMSCs were prepared as previously described (60) . Briefly, epiphyseal growth plates of femurs were cut off and bone marrow was flushed out from the shafts of femurs, tibia and humeri of 7-9-week-old mice. Cell suspension was filtered through a 70 mm cell strainer and cells were cultured in a-MEM with 10% FBS at a density of 3 × 10 6 cells/well in 6-well culture plates. At day 3, half of the medium was replaced with fresh a-MEM. On day 7, cells were switched to a-MEM containing 10% FBS, 100 IU/ml penicillin, 100 mg/ml streptomycin, 50 mg/ml ascorbic acid and 8 mM b-glycerophosphate to induce osteoblast differentiation. Medium was changed every other day.
Matrix expression and mineralization assays in osteoblast cultures
We determined matrix expression and mineral deposition in osteoblast cultures by ALP staining and von Kossa/alizarin red S staining, respectively. ALP staining was performed using a commercially available ALP kit (Sigma) according to the manufacturer's instructions. To visualize mineral nodule formation, osteoblast cultures were stained with 5% silver nitrate solution while exposed to light for 30 min before washing with distilled water. To validate results from von Kossa staining, cells were stained with alizarin red S (AR-S, 40 mM, pH 4.2) for 10 min. AR-S-stained nodules were then extracted by adding 10% (w/v) cetylpyridinium chloride in 10 mM sodium phosphate and incubated for 30 min at room temperature on a shaking platform. The concentration of the AR-S extract was then determined by absorbance measurement at 562 nm as described (61) .
Extracellular pyrophosphate assay
ePPi levels of cultured osteoblasts were measured by a modified radiometric method (21, 62, 63) . This PPi assay uses a UDPG pyrophosphorylase reaction in a system with phosphoglucomutase, glucose-6-phosphate dehydrogenase (G6PDH) and 6-phosphogluconate dehydrogenase to form NADPH. The PPi level was determined by differential adsorption on activated charcoal of UDP-D- H] glucose from its PPicatalyzed reaction product 6-phospho [6- 3 H] gluconate. Sodium pyrophosphate (Fisher Scientific) was used to establish a standard curve (0 -10 mM). PPi was equalized for the DNA content determined by the PicoGreen assay (Molecular Probes) and statistical analysis was performed using Student's t-test. Osteoblasts from Ank null/null mice were used as control for lack of pyrophosphate transport by ANK.
Enzymatic activity of TNAP and PC-1
For the measurement of TNAP activity, cell lysate was added to a substrate solution containing 15 mM 4-nitrophenyl phosphate in 1 M diethanolamine and 0.5 mM MgCl 2 , pH 9.8 (Sigma). The reaction product (p-nitrophenol) was determined colorimetrically by absorbance measurement at 405 nm. To determine the PC-1 activity, cell lysate was added to HEPESbuffered DMEM (25 mM HEPES, pH 7.4) containing 1 mM p-znitrophenyl-thymidine monophosphate (Sigma) and incubated at 378C for 1 h. The reaction was stopped by adding 0.1 M NaOH, and optical density was read at 405 nm. The TNAP and PC-1 activity was normalized to the total protein concentration of the cell lysate as determined by BCA protein assay (Pierce).
RNA analysis
Total RNA from cultured cells or bone tissues was isolated with TRIzol (Invitrogen) according to the manufacturer's instructions. RNA was treated with DNase I (Invitrogen) and cDNA was synthesized using Superscript II reverse transcriptase (Invitrogen). qPCR using iTaq SYBR Green Supermix with ROX (BioRad) was performed in an ABI-7300 instrument (Applied Biosystems). PCR efficiency was optimized and primer specificity was tested by melting curve analysis. Relative quantification of gene expression was determined by the DDCt method and 18S RNA was used for data normalization. PCR primer sequences are listed in Table 1 .
Phosphate, calcium and PTH measurement
Blood for serum analysis in mice was collected from the submandibular vein using animal lancets (Goldenrod; Medipoint) from 6-and 10-week-old male animals after 12 h food and water deprivation. Total serum calcium and phosphate was determined using a calcium reagent kit (Eagle Diagnostics) and a Phosphorus Liquid UV kit (Stanbio), respectively. Serum PTH levels were measured using a two-sided enzymelinked immunosorbent assay (ELISA) specific for intact mouse PTH (Immutopics).
Intramuscular bone explantation
Intramuscular bone explantation was performed as described (37, 38) . Femurs from 4.5-day-old newborn mice were isolated under a dissecting microscope and explanted into the paralateral back muscles of 4-week-old male Ank +/+ and Ank KI/KI recipient mice (n ¼ 6 per group). Bones were radiographically documented prior to explantation. Animals were anesthetized by injecting ketamine/xylazine (150/ 10 mg/kg body weight) intraperitoneally. One femur of a donor mouse was explanted into an Ank +/+ mouse and the other femur into an Ank KI/KI mouse. Each host mouse received one Ank +/+ femur in the left back muscle and one Ank KI/KI femur in the contralateral back muscle. Buprenex (0.08 mg/kg) was given for post-operative pain control. Three weeks after surgery, explanted bones were harvested, radiographed and examined by computed microtomography (mCT) in the MicroCT facility at UCHC (mCT20; ScanCo Medical AG, Bassersdorf, Switzerland). Diaphyseal trabeculation was measured 1.8 mm below the growth plate over a 2 mm distance.
Murine osteoclast cultures
We used three different mouse osteoclast cultures. Murine macrophage-like RAW264.7 cells were grown in a-MEM (10% FBS, 100 IU/ml penicillin, 100 mg/ml streptomycin) with RANKL (30 ng/ml; R&D Systems) to stimulate osteoclast differentiation. Enriched osteoclast progenitors were prepared by FACS with surface markers to obtain a CD11b 2/low CD45R 2 CD3 2 CD115 high subpopulation in bone marrow from Ank +/+ and Ank KI/KI mice (39) . We used commercially available antibodies directly conjugated to various fluorochromes (eBioscience) and sorting was performed in a FACS Aria instrument (Becton Dickinson). Mouse BMM cultures were obtained from bone marrow flushed out from femora and tibia of 7-9-week-old mice and cultured for 18-24 h in a-MEM containing 10% FBS (Hyclone), 100 IU/ ml penicillin and 100 mg/ml streptomycin (InvitrogenGibco). Non-adherent cells were collected and purified by Ficoll separation (Lymphoprep, Axis Shield, Oslo, Norway). Sorted cell populations and BMM cultures were treated with M-CSF only (30 ng/ml; R&D Systems) or M-CSF and RANKL (30 ng/ml) for 5 days to stimulate osteoclast differentiation. For all cultures, cells were seeded at a density of 5000 cells/well on 96-well culture plates for osteoclast assays or 2 × 10 5 cells/well on 6-well plates for RNA isolation.
Osteoclasts derived from human peripheral blood
All work involving human subjects was approved by the UCHC Institutional Review Board. Blood was obtained from healthy controls and CMD patients. Peripheral blood mononuclear cells were isolated as described (64) . Briefly, 8 ml of whole blood was diluted with an equal amount of PBS, layered over 10 ml Ficoll with a density of 1.077 (Lymphoprep) and centrifuged at 800g for 30 min (without break) to precipitate red blood cells. The interface, containing mononuclear cells was collected, diluted with a 3-fold volume of PBS and centrifuged at 290g for 10 min. Pellets were resuspended in 0.83% NH 4 Cl to lyze red blood cells whenever contamination from red blood cells was observed. After counting, cells were plated at a density of 3 × 10 5 cells/well on 96-well plates in a-MEM supplemented with 30 ng/ml human M-CSF, 30 ng/ml RANKL, 5 ng/ml TGF-b1 (R&D Systems) and 1 mM dexamethasone for 15-17 days for TRAP staining and 19 days for resorption assays.
In vitro osteoclast assays
Osteoclast formation and resorption were analyzed by TRAP staining and resorption assays using osteologic discs as described previously (28) . F-actin rings of mature osteoclasts were examined by rhodamine-phalloidin staining (Invitrogen -Molecular Probes). Mature BMMs (day 5 in culture) were washed twice with PBS and fixed with 2.5% glutaraldehyde. Cells were then washed with PBS and permeabilized with ethanol/acetone (1:1) for 30 s at room temperature. After washing with PBS, cells were stained with rhodamine -phalloidin (1:40 dilution in PBS) for 25 min in the dark. Hoechst 33342 dye (trihydrochloride trihydrate; Molecular Probes; 1:1000 in PBS) was used for nuclear staining. Images were taken by a Z1 Observer microscope (Zeiss, Germany). Experiments were performed in triplicate and repeated at least three times.
Live-cell imaging
We performed live-cell imaging on BMM cultures. Briefly, Ank +/+ and Ank KI/KI BMMs were cultured with MCSF and RANKL (30 ng/ml) for 2 days before placing the dish on a temperature-and CO 2 -controlled stage (378C; 6% CO 2 ) using a Z1 Observer Microscope and an Axiocam MRc camera (Zeiss, Germany). Three-minute time-lapse images of Ank +/+ and Ank KI/KI BMM cultures were taken over a period of 6 h alternating between Ank +/+ and Ank KI/KI BMM cultures over 4 days. AxioVision Rel 4.7 software was used to create AVI movies from image stacks. Quantitative measurement of migratory velocity was performed using MetaMorph software (Molecular Devices).
Cocultures of mCOBs and BMMs
mCOBs were prepared from 4-to 7-day-old mice and BMMs were obtained from 7-to 9-week-old mice as described. Osteoblasts (5000 cells/well on osteologic slides; BD Biosciences) were plated 1 day prior to adding BMMs (5000 cells/well). Cocultures were maintained in osteogenic medium (a-MEM with 10% FBS, 50 mg/ml ascorbic acid and 4 mM b-glycerophosphate) supplemented with 10 211 M 1a,25(OH) 2 D 3 and 10 27 M dexamethasone. Cultures on osteologic slides were stained with von Kossa after 12 days in culture to determine resorptive activity.
Bone marrow transplantation
We used 4-week-old male donor and recipient mice to generate bone marrow chimera. Ank +/+ and Ank KI/KI donor mice (N10 for C57Bl6) were obtained by crossing Ank +/KI mice with transgenic mice overexpressing GFP driven by a MHC Class I, H-2k b promoter to obtain GFP-selectable bone marrow cells. To cause myeloablation, recipient mice were irradiated by giving 11 Gy administered in two split doses of 5.5 Gy each in an interval of 4 -5 h. To rescue hematopoiesis, recipient mice were injected with 10 × 10 6 bone marrow cells from donor femurs through retro-orbital injection in a 100 ml volume 4 -5 h after the second irradiation. Eight weeks after transplantation, the degree of chimerism was confirmed by FACS analysis for GFP. Skulls, mandibles and femurs were evaluated by X-ray radiography and computed microtomography (mCT) in the MicroCT facility at UCHC (mCT20; ScanCo Medical AG). Calvariae were analyzed over an area of 100 slices using the sagittal suture of the central parietal region as reference point. Mandibular data were collected by measuring vertical sections at the mandibular foramen. Metaphyseal trabecular measurements of femurs were taken at the distal growth plate in 80 consecutive slices of 12 mm resolution over a distance of 960 mm. Diaphyseal trabeculation in femurs was determined 2.4 mm from growth plate (200 slices) and extending 3.6 mm (300 slices). Volumetric regions were rendered as three-dimensional arrays with an isometric voxel dimension of 12 mm. Fifty cross-sectional slices of 12 mm in the mid-diaphysis were used to calculate cortical bone parameters.
Statistical analysis
Statistical analysis was performed using Prism 5 software (GraphPad Software).
